United Therapeutics | UTHR - Créances Commerciales





Créances Commerciales Changement Date
Amarin USD 126.83M 477K 2025-12
Ardelyx USD 71.85M 4.76M 2025-12
Baxter International USD 2.01B 231M 2025-12
Bayer EUR 14.19B 720M 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
J&J USD 21.33B 3.72B 2025-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
Moderna USD 184M 862M 2025-12
Omeros USD 8.08M 440K 2024-06
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 181.62M 21.45M 2025-12
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Teva Pharmaceutical Industries USD 3.71B 101M 2025-12
United Therapeutics USD 350.2M 52.5M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12